Belite Bio, Inc
BLTE
$148.73
-$1.10-0.73%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
5/20/2026
-
MarketBeat
6/25/2026
-
Simply Wall St
6/21/2026
-
Simply Wall St
6/17/2026
-
Simply Wall St
6/15/2026
-
The Cerbat Gem
6/14/2026
-
TipRanks: TheFly
6/14/2026
-
Simply Wall St
6/13/2026
-
The Cerbat Gem
6/13/2026
-
Globe Newswire
6/12/2026
-
The Cerbat Gem
6/8/2026
-
Seeking Alpha: Transcripts
6/8/2026
-
SeekingAlpha
6/8/2026
-
Simply Wall St
6/2/2026
-
Globe Newswire
6/1/2026
-
Benzinga
A Look At Belite Bio (BLTE) Valuation After Wider First Quarter Net Loss And Mixed Share Price Moves
5/29/2026
-
Simply Wall St
5/29/2026
-
The Cerbat Gem
5/27/2026
-
SeekingAlpha
5/27/2026
-
Tickeron - Stocks
5/26/2026
-
TipRanks Financial Blog
5/26/2026
-
TipRanks Financial Blog
5/26/2026
-
TipRanks Financial Blog
5/23/2026
-
Tickeron - Stocks
5/22/2026
-
SeekingAlpha
10/2/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Tuesday, March 31, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
(est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
858 246 6240
Address
12750 High Bluff Drive
San Diego, CA 92130
San Diego, CA 92130
Country
Year Founded
Business Description
Sector
Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics with unmet medical needs in the United States. Its lead...
more